Predictors of clinically meaningful bone mineral density gains with romosozumab: An explainable machine leaning analysis of a real-world cohort
Romosozumab was effective and well-tolerated in routine clinical practice, yielding meaningful and site-specific gains in BMD. Explainable machine-learning analysis identified physiologically coherent and consistent clinical predictors of ≥10 % response.
Authors
- David Castro Corredor (ORCID: https://orcid.org/0000-0001-7315-6274)
- Luis Ángel Calvo Pascual (ORCID: https://orcid.org/0000-0002-8818-5542)
Institutions
- Hospital General Universitario de Ciudad Real (ES)
- Universidad Pontificia Comillas (ES)
Publication Details
- Journal
- Bone Reports
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1016/j.bonr.2025.101890
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00